Needle assisted jet injector

ABSTRACT

A jet injection device with a fluid chamber in a housing member for holding about 0.02 ml to about 3 ml of a medicament. An injection-assisting needle has an injection end that extends from the housing for inserting into a patient to a depth of up to about 5 mm. A force-generating source is configured to apply a pressure reaching about 100-1000 psi to the medicament in the chamber to expel the medicament through the injecting end of the needle.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a division of co-pending U.S. application Ser. No.10/861,420, filed Jun. 7, 2004, which is a division of U.S. applicationSer. No. 09/779,603, filed Feb. 9, 2001, now U.S. Pat. No. 6,746,429,which is a continuation of International Patent Application No.PCT/US99/17946, filed Aug. 10, 1999, which claims priority to U.S.Provisional Application No. 60/096,464, filed on Aug. 11, 1998. Theentire content of these applications is expressly incorporated herein byreference thereto.

FIELD OF THE INVENTION

The present invention is directed to a device for delivery ofmedicament, and in particular to a jet injector with a short needle toreduce the pressure at which the jet injector must eject the medicamentfor proper delivery.

BACKGROUND OF THE INVENTION

A wide variety of needleless injectors are known in the art. Examples ofsuch injectors include those described in U.S. Pat. No. 5,599,302 issuedto Lilley et al., U.S. Pat. No. 5,062,830 to Dunlap, and U.S. Pat. No.4,790,824 to Morrow et al. In general, these and similar injectorsadminister medication as a fine, high velocity jet delivered undersufficient pressure to enable the jet to pass through the skin.

As the skin is a tissue composed of several layers and the injector isapplied to the external surface of the outermost layer, the deliverypressure must be high enough to penetrate all layers of the skin. Thelayers of skin include the epidermis, the outermost layer of skin, thedermis, and the subcutaneous region. The required delivery pressure istypically greater than approximately 4000 p.s.i. (27,579 kPa) (measuredas the force of the fluid stream divided by the cross-sectional area ofthe fluid stream).

Although this pressure is readily achievable with most injectors, thereare some circumstances in which delivery of medicament to thesubcutaneous region under a reduced pressure is desirable. For example,drugs that require a specific molecular structural arrangement, such asa linear protein configuration, may be rendered ineffective due to shearforces caused by the delivery of the drug at high pressures that alterthe structural arrangement of the drug. As it is more difficult todeliver a large volume of fluid at a high pressure compared to a smallvolume, using a lower pressure facilitates delivery of a larger volumeof fluid. Furthermore, the lower pressure could make manufacturing aninjector device less expensive. The lower pressure would also reduceadverse stresses on the device and result in a corresponding increaseduseable device lifetime. Moreover, the lower pressure would make jetinjection compatible with medicament stored and delivered in glassampules, which typically cannot withstand the pressure typically reachedby jet injectors.

One of the advantages associated with jet injectors is the absence of ahypodermic needle. Given the aversion to needles possessed by some, theabsence of a needle provides a psychological benefit. Even devices thatutilize conventional hypodermic needles have attempted to capitalize onthis psychological benefit. For example, self-injectors orauto-injectors like the ones disclosed in U.S. Pat. Nos. 4,553,962,4,378,015 and PCT International Publication numbers WO 95/29720, WO97/14455 have retractable needles which are hidden until activation.Upon activation, the needle extends from the bottom of the device andpenetrates the user's skin to deliver medicament. As none of thesedevices involves delivery of the medicament using jet injection, themedicament delivery location is limited by the length of the needle. Forexample, if delivery in the subcutaneous region is desired, the needlemust be long enough to reach the subcutaneous region. Furthermore, asauto-injectors operate like syringes, the injection time is severalseconds or longer. In contrast, jet injectors typically inject infractions of a second.

U.S. Pat. No. 5,304,128 to Haber et al. describes a jet injectingsyringe that uses a short needle to assist injection. The syringe uses agas powered driven plunger to force medication through the syringe andout of the needle. The needle is retracted until the syringe isactivated and then is extended to puncture the skin of the personinjected. However, the needle remains extended after the syringe isused. The extended needle could lead to potential biohazards and safetyconcerns, such as accidental injections and spreading of diseases. Also,the gas powered plunger is both complicated and expensive tomanufacture.

PCT Publication No. WO 99/03521 of Novo Nordisk discloses an undefinedconcept of “jet” injection. However, this publication does not teach onethe details of the driving mechanism necessary to practice the concept.

PCT Publication No. WO 99/22790 of Elan Corporation teaches a needleassisted injector having a retractable shield that conceals the needleboth before and after use of the injector. The disclosed injector has adriving mechanism that operates on pressure created by a chemicalreaction. Because of this chemically operated driving mechanism, theinjecting time for the injector is at least three seconds and morelikely greater than five seconds. This relatively long injection timemay create discomfort in the patient receiving the injection. Also, theneedle may move during the lengthy injection and add to the patientsdiscomfort.

Even with minimally invasive medical procedures, it is advantageous tomaintain the time for the procedures at a minimum. Thus, there exists aneed for a needle assisted jet injector that operates at relatively lowpressure and that is capable of quickly delivering medicament. Therealso exists a need for such an injector having a retractable orconcealed needle to prevent the medical hazards associated with exposedneedles.

SUMMARY OF THE INVENTION

The present invention relates to a needle assisted jet injector. In oneembodiment, the injection device includes a housing; a retractableinjection-assisting needle at a distal end of the injector; a nozzleassembly defining a fluid chamber having an opening for slidinglyreceiving at least a portion of the needle and being removablyassociated with the housing; a plunger movable in the fluid chamber; atrigger assembly; and a force generating source operatively associatedwith the trigger assembly so that movement of the trigger assemblyactivates the energy source to move the plunger in a first direction toexpel a fluid from the fluid chamber. The retractableinjection-assisting needle has a needle tip located at a distal end ofthe needle with at least a portion configured and dimensioned to slidethrough the nozzle assembly opening; a discharge channel within theneedle tip and terminating in an orifice through which the fluid isexpelled; a body portion to direct fluid towards the discharge channel;a plunger receptor configured and dimensioned to receive at least aportion of the plunger; and a retraction element operatively associatedwith the needle and disposed substantially within the nozzle assembly.The needle is located within the nozzle assembly in a retracted positionprior to activation of the force generating source. Movement of theplunger in the first direction upon activation of the energy sourceresults in at least a portion of the needle tip extending beyond thenozzle assembly opening to a needle insertion point and expelling thefluid through the needle tip and past the needle insertion point to aneedle injection site. The needle insertion point is located at theneedle tip, and the needle injection site is distal to the needle tip.The retraction element returns the needle tip to the retracted positionafter activation of the energy source.

The retraction element may be a resilient O-ring, a spring, or aflexible membrane which moves to allow extension of the needle tipbeyond the nozzle assembly opening and then returns to its originalposition to return the needle tip to its retracted position. The needlebody can have an exterior surface which includes a ridge or recess foraccommodating the retraction element. A shoulder can be disposed betweenthe needle tip and the needle body for accommodating the retractionelement. Preferably, the needle tip, when extended, has a length ofapproximately 1-5 mm.

In a preferred embodiment, the jet injector includes a housing havingdistal and proximal ends; a fluid chamber having a seal at one end andlocated within the housing for holding at least about 0.02 ml to 3 ml ofa medicament; an injection-assisting needle having an injecting end anda piercing end and coupled to the distal end of the housing; a plungermovable within the fluid chamber; a force generating source capable ofproviding sufficient force on the plunger to eject an amount up to about3 ml of the medicament from the fluid chamber in less than 2.75 seconds;a needle guard located at the distal end of the housing for concealingthe needle, the needle guard being moveable between a protectingposition and an injecting position; and an activation elementoperatively associated with the needle guard. The needle is moveablebetween a medicament storing position and a medicament deliveringposition. When the needle is in the medicament storing position, it isisolated from the fluid chamber. When the needle is in the medicamentdelivering position, the piercing end punctures the seal to provide afluid pathway from the fluid chamber through the needle. Retraction ofthe needle guard exposes the injecting end of the needle to an insertionpoint and activation of the force generating source moves the plunger toexpel medicament from the fluid chamber and thereby eject the amount ofthe medicament through the injecting end of the needle and past theneedle insertion point to an injection site in less than 2.75 seconds.The needle insertion point is located at the injecting end of theneedle, and the injection site is distal to the injecting end of theneedle.

Retraction of the needle guard from the protecting position to theinjecting position may activate the force generating source, whichprovides sufficient force to eject an amount of about 1 to 2 ml of themedicament in less than about 2.5 seconds. The jet injector can alsoinclude a locking element associated with the needle guard for lockingthe needle guard in the protecting position after activation of theinjection device and after return of the needle guard to the protectingposition, to prevent re-exposure of the needle.

The activation element can include an inner housing located inside thehousing and having trigger projections for maintaining the plunger in anidle position; and a latch located inside the housing andcircumferentially surrounding the inner housing, the latch beingmoveable between a firing position and an armed position. Retraction ofthe needle guard to the injecting position urges the latch toward thefiring position, thereby releasing the trigger projections from theplunger and activating the injection device.

The jet injector can further include an elastomeric element, such as aspring element, that acts upon the needle guard and urges the needleguard toward the protecting position; wherein the elastomeric elementreturns the needle guard to the protecting position after the medicamenthas been ejected from the needle, thereby substantially re-enclosing theneedle.

The needle is mounted on a needle holder operatively associated with theneedle and the distal end of the housing, such that rotation of theneedle holder places the needle in fluid communication with the fluidchamber. Preferably, the needle has a tip with a length of approximately1-5 mm and the medicament is ejected at a pressure between around 100 to1000 p.s.i. (689 to 6895 kPa) and at a rate of at least 0.40 ml/sec.

The jet injector may also include a removable safety cap operativelyassociated with the distal end of the injection device such thatrotation of the safety cap imparts rotation on the needle. At least aportion of the housing is made of a transparent or translucent materialfor allowing viewing of the fluid chamber. The medicament is preferablyejected at a pressure between around 100 to 500 p.s.i. (689 to 3448 kPa)and at a rate of about 0.50 ml/sec so that about I ml of the medicamentis ejected in about 2 seconds.

The fluid chamber may comprise an ampule having a distal end, a proximalend and an opening in each of the distal and proximal ends; a pierceableseal associated with the opening in the distal end; and a stopperlocated in the proximal end of the ampule for maintaining the medicamentinside the ampule. An alternative fluid chamber may be used such thatactivation of the force generating source moves the pierceable sealtowards the injection assisting needle to pierce the seal and moves thestopper to eject medicament from the injection assisting needle.

The present invention also relates to a method of delivering medicamentto an injection site of a patient. The method includes the steps ofextending a needle from a shield prior to inserting the needle into theneedle insertion point, the shield initially concealing the needle;inserting the needle into the needle insertion point to a depth of lessthan 5 mm, with the needle being in fluid communication with a fluidchamber that contains at least about 0.02 to 2 ml of the medicament; andapplying a force sufficient to eject the medicament from the fluidchamber and through the needle to deliver the medicament to theinjection site in less than about 2.75 seconds. The needle insertionpoint is located more superficial than the injection site.

Preferably, the initial pressing of the shield against the injectionsite causes activation of the energy mechanism and may establish fluidcommunication between the needle and the fluid chamber. An additionalstep includes retracting the needle into the shield after the desiredamount of medicament has been delivered to the injection site andwherein the applied force for injecting the medicament is sufficient toeject an amount of about 1 to 2 ml of the medicament in less than about2.5 seconds. The needle has a length of approximately 1-5 mm and themedicament is ejected at a at a pressure between around 100 to 1000p.s.i. (689 to 6895 kPa) and at a rate of at least 0.40 ml/sec.Preferably, the medicament is ejected at a pressure between around 100to 500 p.s.i. (689 to 3448 kPa) and at a rate of about 0.50 ml/sec sothat about 1 ml of the medicament is ejected in about 2 seconds.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a cross-sectional view of a needle assisted jet injectoraccording to the present invention;

FIG. 2 is a cross-sectional view of the needle on the jet injector ofFIG. 1;

FIG. 3 is a perspective view of the needle of FIG. 2;

FIG. 4 is an enlarged cross-sectional view of the jet injector of FIG. 1with the needle in the retracted position;

FIG. 5 is an enlarged cross-sectional view of the jet injector of FIG. Iwith the needle in the extended position;

FIG. 6 is a perspective view of a second embodiment of the needleaccording to the present invention;

FIG. 7 is a partial cross-sectional view of a jet injector according tothe present invention with the needle of FIG. 6 in the retractedposition;

FIG. 8 is a partial cross-sectional view of a jet injector according tothe present invention with the needle of FIG. 6 in the extendedposition;

FIG. 9 is a cross-sectional view of another embodiment of the presentinvention with a flexible member as the retraction element and theneedle in the retracted position;

FIG. 10 is a cross-sectional view of the embodiment of FIG. 9 with theneedle in the extended position;

FIG. 11 is a cross-sectional view of a two piece nozzle assembly havinga fixed needle;

FIG. 12 is a cross-sectional view of another embodiment of a two piecenozzle assembly having a fixed needle;

FIG. 13 is a cross-sectional view of another embodiment of a two piecenozzle assembly having a fixed needle;

FIG. 14 a is a cross-sectional view of a needle assisted jet injectoraccording to a preferred embodiment of the present invention;

FIG. 14 b is a cross-sectional view of the needle assisted jet injectorof FIG. 14 a taken along a plane perpendicular to that of FIG. 14 a;

FIG. 15 is a perspective view of the outer housing of the needleassisted jet injector of FIGS. 14 a and 14 b;

FIG. 16 is a perspective view of the inner housing of the injector ofFIGS. 14 a and 14 b;

FIG. 17 is an elevational view of the ram of the injector of FIGS. 14 aand 14 b;

FIG. 18 a is perspective view of the latch assembly of FIGS. 14 a and 14b;

FIG. 18 b is a cross-sectional view of the latch assembly of FIGS. 14 aand 14 b taken along line A-A of FIG. 18 a;

FIG. 19 is a perspective view of the needle holder of FIGS. 14 a and 14b;

FIG. 20 a is a cross-sectional view of the cartridge assembly of FIGS.14 a and 14 b;

FIG. 20 b is s cross-sectional view of an alternative embodiment of thecartridge assembly of FIGS. 14 a and 14 b;

FIG. 21 a is a cross-sectional view of the needle assembly of FIGS. 14 aand 14 b;

FIG. 21 b is a cross-sectional view of the injecting needle of FIGS. 14a and 14 b;

FIG. 22 a is a perspective view of the needle guard of FIGS. 14 a and 14b;

FIG. 22 b is a cross-sectional view of the needle guard of FIGS. 14 aand 14 b taken along line A-A of FIG. 22 a;

FIG. 23 a is a perspective view of the needle guard cap of FIGS. 14 aand 14 b;

FIG. 23 b is a perspective view of the needle guard cap of FIGS. 14 aand 14 b;

FIG. 24 is a perspective view of the locking ring of FIGS. 14 a and 14b;

FIG. 25 is a perspective view of the safety cap of FIGS. 14 a and 14 b;

FIG. 26 is a cross-sectional view of the needle cap of FIGS. 14 a and 14b;

FIG. 27 is a schematic expressing a pressure-time curve for a jetinjector.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

For convenience, the same or equivalent elements of the invention ofembodiments illustrated in the drawings have been identified with thesame reference numerals. Further, in the description that follows, anyreference to either orientation or direction is intended primarily forthe convenience of description and is not intended in any way to limitthe scope of the present invention thereto.

As shown in FIG. 1, a jet injector 10 according to the present inventioncomprises a nozzle assembly 12 attached to a housing 14. As used in thisapplication, the term distal shall designate the end or direction towardthe front of jet injector 10. The term proximal shall designate the endor direction toward the rear of the injector. The term longitudinaldesignates an axis connecting nozzle assembly 12 to jet injector 10, andthe term transverse designates a direction substantially perpendicularto the longitudinal direction including arcs along the surface of jetinjector 10, or nozzle assembly 12.

Nozzle assembly 12 can be threadably connected to housing 14 such thatit can be readily attached and detached. Alternatively, other knownstructures for mounting or attaching two components can be utilized aswell to detachably mate nozzle assembly 12 to housing 14. In thismanner, injector 10 can be reused with various nozzle assemblies thatmay contain different medications of different doses either together orat different times. For instance, nozzle assembly 12 can be prefilledwith medication and disposed of after each use. Further, a medicationfilling device such as a coupling device can be used to fill the fluidchamber with medication. U.S. Pat. No. 5,769,138 to Sadowski et al., thedisclosure of which is herein incorporated by reference, is directed tosuch a coupling device.

A trigger assembly 16 is located at the proximal end of housing 14.Trigger assembly 16 activates and triggers an energy source or forcegenerating means 18 which forces medicament out of nozzle assembly 12.Energy source 18 can be a coil spring, a gas spring, or a gaspropellant.

According to a first embodiment of the present invention, nozzleassembly 12 has an injection assisting needle 20 movable within nozzleassembly 12. Needle 20 will be discussed in detail after firstdescribing the other components of injector 10. The nozzle assembly 12includes a nozzle member 22 having an opening 24 at the distal end,preferably having a diameter of about 0.04-0.4 inches (1.016 mm to10.160 mm) or any other suitable diameter that would allow for theintroduction of injection assisting needle 20 therein. Nozzle member 22includes a cylindrical fluid chamber 26 terminating at the distal end ina right circular cone 28. Cone 28 can be a convex cone (as shown), aright circular cone, or any other suitable configuration. A plunger 30having a pressure wall contoured to cone 28 is positioned to slidewithin fluid chamber 26. Plunger 30 can include sealing means such asone or more O-rings or the like (not shown) that are formed around itsouter periphery to provide a seal, or the plunger itself can be a seal,as described in U.S. Pat. No. 5,062,830, the disclosure of which isincorporated herein by reference. The plunger can also includeadditional sealing means at spaced intervals to provide a better seal.

Plunger 30 is connected to a ram 32 which in turn is connected to energysource 18. Alternatively, ram 32 can be integrally formed with an energymechanism if desired. An inertia mass 34 is connected to or integrallyformed with ram 32 near the end of ram 32 closest to plunger 30. Inertiamass 34 can be removably connected to ram 32 such that the mass can beadjusted to accommodate different types of injections, taking intoconsideration, for instance, the viscosity of the medication, theinitial pressure build up desired, the strength of energy source 18, andthe depth of injection penetration, etc. Inertia mass 34 cooperates withram retainer 36 to limit the distance that ram 32 can travel towardnozzle assembly 12. One important safety aspect of this feature is thatram 32 cannot become a dangerous projectile if injector 10 is fired whennozzle assembly 12 is not present.

Trigger assembly 16 includes a trigger extension 38 having a triggerengaging notch 40. Trigger extension 38 is attached to the end of ram32, for example, by a threaded engagement. Trigger assembly 16 alsocomprises a latch housing sleeve 42 fixedly attached to an actuatingmechanism 44. Actuating mechanism 44 is shown as a threaded couplingthat operates by rotation movement. Latch housing sleeve 42 has athroughbore dimensioned to allow passage of trigger extension 38. Latchhousing sleeve 42 further has a plurality of sidewall openings 46dimensioned to allow passage of balls or ball bearings 48. A tubularbutton 50 having one open end and a closed end is telescopinglypositioned with latch housing sleeve 42 as shown. Button 50 has acircumferential or annular groove 52 formed on an inner wall 54 thereofto allow portions of the balls 48 to engage groove 52 when triggerassembly 16 is in the fired position, i.e., not engaged with triggerextension 38 (not shown). Balls 48 are positioned so that they aresubstantially flush with an inner side wall surface 56 of latch housingsleeve 42 to allow trigger extension 38 to pass through latch housingsleeve 42. A latch ball retaining cup 58 is telescopingly positionedwithin button 50. A compression spring 60 is positioned between the cup58 and button 50 to bias button 50 and cup 58 away from each other inthe axial direction.

The structure of injection assisting needle 20 is best seen in FIGS. 2and 3. Needle 20 has a plunger receptor 62 at the proximal end which isconfigured to accommodate plunger 30 as it slides within fluid chamber26. Although plunger receptor 62 can be of any shape conforming to theexterior profile of plunger 30, it is preferably conical. A needle innerwall 64 is contoured to narrow like a funnel to a needle dischargechannel 66 to accelerate the fluid as it is discharged. Needle dischargechannel 66 extends to a discharge orifice 68 at the distal end of needle20. Needle discharge orifice 68 has a diameter of 0.004 to 0.012 inches(0.102 to 0.305 mm). Preferably, the diameter is 0.005 to 0.0075 inches(0.127 to 0.191 mm).

The outer periphery of needle 20 can be of varied geometries such thatit fits within fluid chamber 26 of nozzle assembly 12. Advantageously,needle 20 has a conical body section 70 which narrows gradually ortapers towards a cylindrical body section 72 of smaller circumference.Preferably, a shoulder 74 is positioned to separate a needle tip 76 fromcylindrical body section 72. Needle tip 76 is also cylindrical, but hasa smaller circumference than cylindrical body section 72 such thatneedle tip 76 can fit within and extend through opening 24 of nozzleassembly 12. However, cylindrical body section 72 of needle 20 has acircumference such that shoulder section 74, existing at the transitionbetween cylindrical body section 72 and needle tip 76, preventscylindrical body section 72 from existing within opening 24. The lengthof needle tip 76 from its end to shoulder 74 is approximately 1 to 5 mm.Thus, needle tip 76 will penetrate the skin to a depth less than 5 mm.It should also be noted that although needle tip 76 is shown having asingle beveled end at a 45° angle, needle tip 76 can have any shape thatpenetrates the skin.

As shown in FIGS. 4 and 5, needle 20 is positioned coaxially andretractably within the distal end of fluid chamber 26 such that wheninjector 10 is fired, needle tip 76 extends out opening 24 of nozzleassembly 12 at a speed sufficient to penetrate the outer layer of skin.By inserting needle tip 76 to a depth less than 5 mm, typically only theepidermis of the skin is penetrated and the pressure needed to deliverthe medicament to the desired region by jet injection is lower than thatwould otherwise be needed with needleless jet injection. While deliveryof medicament by syringes and auto-injectors is limited by the length ofthe needle, the needle assisted jet injector according to the presentinvention delivers the medicament to a depth deeper than the length ofthe needle. This depth can include any region of the skin and beyondincluding intradermal, subcutaneous, and intramuscular.

To provide a seal between needle 20 and fluid chamber 26, needle 20includes a sealing means such as an O-ring 78 or the like formed aroundthe outer periphery of needle 20 and accommodated by slot 80. In analternative embodiment shown in FIG. 6, needle 120 itself is the seal.Thus, slot 80 is not needed. Needle 120 also differs from needle 20 inthat cylindrical body section 72 is absent so that conical body section70 terminates at shoulder 74.

FIG. 5 illustrates injection assisting needle 20 in its extendedposition. Needle tip 76 extends beyond the distal end of nozzle assembly12. Shoulder 74 abuts the bored out inner section of nozzle opening 24to prevent needle 20 from extending beyond needle tip 76. A retractionelement 82, in this embodiment a spring, is compressed to provide arecoil force once the medicament is expelled so that needle tip 76 willretract back into nozzle opening 24. Needle 20 preferably has a ridge84, the distal surface of which provides an annular area for thecompression of retraction element 82. Alternatively, a washer can beused instead of the ridge 84 to contain O-ring 78 and compress theretracting mechanism during operation.

FIGS. 7 and 8 show needle 120 of FIG. 6 with nozzle assembly 12 in whichretraction element 82 is a resilient O-ring or other like material knownto those skilled in the art. When an O-ring is used as retractionelement 82, it can also act as a sealing mechanism, and for this reasonthe O-ring is preferred. The interior of needle 120 is similar to thatof needle 20. FIG. 7 illustrates needle 120 in the retracted condition,before expelling medicament, and FIG. 8 shows the extended conditionduring which medicament is expelled. Similar to embodiments previouslydescribed, this embodiment functions to extend the needle tip 76 beyondnozzle opening 24 and penetrate the outer layer of the patient's skinduring operation. Also, similar to embodiments previously described,needle 120 also preferably has ridge 84 around the proximal end toprovide a surface which compresses the resilient material when theinjector is triggered.

Another embodiment of the present invention, shown in FIGS. 9 and 10,uses a flexible member 86 as the retraction element. FIG. 9 illustratesthe neutral condition before expelling the medicament. Flexible membrane86 spans between walls 88 of nozzle assembly 12 which define fluidchamber 26 for holding medicament. Similar to embodiments previouslydescribed, the distal end of nozzle walls 88 act to conceal needle tip76 until the injector is fired. Needle 220 is attached to flexiblemembrane 86 by any conventional means known to those skilled in the art.Preferably, needle 220 is integrally attached to flexible membrane 86with an adhesive. FIG. 10 shows needle 220 in its extended positionwhere the needle tip 76 extends beyond the end of walls 88 such thatneedle tip 76 penetrates the outer layer of skin to allow injection anddeliver of the medicine at reduced pressure.

Other embodiments of the present invention relate to injectors with afixed needle, i.e. a non-retracting needle that permanently extendsbeyond the nozzle assembly. Both a one-piece and a two-piece nozzleassembly with a fixed needle can be used and are contemplated by thisinvention.

FIGS. 11 and 12 show embodiments of the present invention with a twopiece nozzle assembly with a fixed needle 320. A first section 90 ofnozzle assembly 12 has needle 320 at the distal end and can either beattached internally or externally to a second section 92 to form nozzleassembly member 12. Although any conventional attaching means can beused, such as solvent or adhesive bonding, FIG. 11 shows a preferablefriction-fitting or snapping attaching means 94 for both internal andexternal attachment of first section 90 and second section 92. FIG. 12shows a preferable ultrasonic bonding means 96 of attachment. Althoughultrasonic bonding features 96 can be placed at any location to attachthe two pieces, preferably, the ultrasonic bonding features 96 are alongthe distal end at the interface between first and second sections 90, 92to facilitate ease of manufacturing.

Another embodiment of a multi-piece nozzle assembly with fixed needle320 is shown in FIG. 13. The nozzle assembly consists of nozzle member22 having an opening 24 designed to receive a tubular insert to createfixed needle 320. Although FIG. 13 shows a multi-piece nozzle assembly,fixed needle 320 can be made to be integral with nozzle assembly 12.

FIG. 14 a and FIG. 14 b depict a preferred embodiment of the presentinvention having a retractable shield around the needle. An innerhousing 25, shown in FIG. 16, snaps inside an outer housing 45, using apair of snaps 65 located on the inner housing 25. The snaps 65 protrudethrough openings 85 in the outer housing 45, shown in FIG. 15, andmaintain the inner housing 25 and the outer housing 45 in a fixedrelationship with one another. Other techniques known in the art, suchas gluing and welding, could be used to hold the inner housing 25 andouter housing 45 together.

The inner housing 25 has three trigger protrusions 100 extending fromits distal end. These trigger protrusions 100 are shaped to mate with anannular recess 140 in ram 125 (FIG. 17). Ram 125 is urged toward thedistal end of the injector with a compression spring 240, however otherenergizing devices capable of producing an injection of up to 2 ml inabout 2.5 seconds or less could be used. These energizing sourcestypically include rubber elastomers and compressed gas cartridges. Alatch 160, shown in FIG. 18 a, is slidable inside the outer housing 45and surrounds the inner housing 25. The latch 160 has a barrel portion180 at its distal end and a pair of extensions 200 at its proximal end.When the jet injector is ready to be fired, ridge 225 on the barrelportion 180, shown in FIG. 18 b, contacts the trigger protrusions 100and maintains them in the annular recess 140 in ram 125, preventing theram 125 from firing under the force of compression spring 240.

A needle holder 260, shown in FIG. 19, mounts onto the inner housing 25with right hand threads 280 and holds a cartridge assembly 300 insidethe inner housing 25. As best shown in FIG. 20 a, the cartridge assembly300 consists of a glass ampule 320 having an opening 340 in its proximalend and a seal 360 on its distal end. The glass ampule 320 typicallyholds between 0.02 and 2 mL of a medicament 400. Instead of glass, theampule 320 can also be constructed of metal or other suitable materialsknown in the art. A rubber stopper 380 is slideable within the glassampule 320 and seals the opening 340 in its proximal end of the glassampule 320 so the medicament 400 stays inside the glass ampule 320. Theseal 360 on the distal end comprises a rubber seal 420 formed on the endof the ampule 320 by conventional techniques, such as an aluminum cap440 having a hole in its end. The ram 125 extends into the opening 340in the proximal end of the glass ampule 320 and abuts the rubber stopper380. To provide a visual indication of the device's status, at least aportion of the outer housing 45 is constructed of transparent ortranslucent material, so that the cartridge assembly 300 can be viewedby the user.

A needle assembly 460, shown in FIG. 21, consists of an injecting needle480 glued inside a longitudinal pocket 500 in the needle hub 520.Grooves or other surface treatment on the longitudinal pocket 500 and onthe injecting needle 480 enhance bonding between the injecting needle480 and the needle hub 520. Alternatively, other known methods offixing, such as molding, may be used to secure the injecting needle 480to the needle hub 520.

To allow for an appropriate injection time, the injecting needle 480 isof 27 gauge, however other gauges may be suitable for differentapplications. The length of the needle 480 that extends beyond thedistal end of the needle hub 520, and is used for injection, ispreferably between 1 and 5 mm. As shown in FIG. 21 b, the injectingneedle 480 preferably has a 30 □ point. This angle decreases the lengthof the bevel 481 and thereby increases the effective length of the lumen483. The increase in the effective length of the lumen 483 reduces thepercentage of incomplete injections.

Needle assembly 460 is mounted to the needle holder 260, and clockwiserotation of the needle holder 260 approximately one quarter of a turnthreads it further into the inner housing 25 and forces the proximal endof the injecting needle 480 through rubber seal 420, thereby creatingthe drug path.

A needle guard 540, depicted in FIG. 22 a , is located at the distal endof the injecting device and conceals the injecting needle 480. Theneedle guard 540 snaps together with the needle guard cap 560, which isshown in FIGS. 23 a and 23 b. The needle guard cap 560 slides onextensions 200 of the latch 160, thereby allowing the needle guard 540to slide longitudinally on the distal end of the injector to expose theinjecting needle 480. Feet 580 at the end of extensions 200 prevent theneedle guard cap 560 and consequently the needle guard 540 from slidingcompletely off the end of the device.

Recesses 600 in the needle guard 540 and corresponding bosses 620 on theneedle holder 260 translate any rotation of the needle guard 540 intorotation of the needle holder 260. Abutments 655 on the inner surface ofthe needle guard cap 560, shown in FIG. 23 b, are positioned relative tothe feet 580 of the latch 160 to inhibit counter-clockwise rotation ofthe needle holder 260. This prevents the user from unscrewing the deviceand removing the cartridge assembly 300 from it.

The needle guard cap has a inner flange 635 with a pair of cutouts 645therein. The cutouts 645 correspond to the pair of bosses 625 on theinner housing 25. The flange 635 acts to prevent motion of the needleguard cap 560 and the needle guard 540 toward the proximal end of thedevice unless the cutouts 645 are rotated into alignment with the pairof bosses 625. This acts as a safety feature to prevent accidentalfiring of the injector. Alternatively, other known mechanisms, such as aremovable safety strip can be used to prevent accidental firing of theinjector.

A return spring 660 rests on the needle holder 260 and urges the needleguard 540 toward the distal end of the injector, thereby keeping theinjecting needle 480 concealed. A pair of stops 640, shown in FIG. 23,extend from the needle guard cap 560 and are positioned relative tobosses 625 on the inner housing 25 such that the needle guard 540 andneedle holder 260 cannot rotate clockwise under the force of returnspring 660.

Pressing the needle guard 540 toward the proximal end of the devicecauses the needle guard cap 560 to push the latch 160 longitudinallytoward the proximal end of the device, thereby moving the ridge 225 onthe barrel portion 180 of the latch 160 off the trigger protrusions 100on the inner housing 25. This allows the trigger protrusions 100 to flexout of the annular recess 140 in the ram 125, thereby causing the ram125 to fire under the force of compression spring 240. When the ram 125fires, it slides rubber stopper 380 in the glass ampule 320 toward thedistal end of the device, causing the medicament 400 to flow through thedrug path (created by turning the needle holder 260 clockwise onequarter turn prior to firing, as discussed above) and eject from theinjecting needle 480.

As depicted in FIG. 22 b, needle guard 540 has a pocket 680 locatedtherein. A locking ring 700, shown in FIG. 24, sits in pocket 680 andprevents re-exposure of the injecting needle 480 after the device hasbeen fired. Locking ring 700 has multiple splayed legs 720 and anundercut 740 that mates with extensions 760, which protrude from theneedle holder 260. Upon depression of the needle guard 540 toward theproximal end of the device, extensions 760 engage the undercut 740 andbecome locked thereon. When the needle guard 540 returns to its originalposition, the locking ring 700 is pulled from pocket 680 in the needleguard 540 and splayed legs 720 expand radially outward. Upon an attemptto re-depress the needle guard 540, splayed legs 720 catch shoulder 780on the needle guard 540 and restrict further movement of the needleguard 540, thereby preventing re-exposure of the injecting needle 480.

The device also features a removable safety cap 800 that slides over theneedle guard 540 and covers the device prior to its use. The safety cap800 includes a needle cap 820 (FIG. 26) connected thereto, the needlecap 820 forming a sterile barrier around the needle assembly 460. Asshown in FIG. 25, the safety cap 800 has four longitudinal recesses 860equally displaced about its inner surface 840. These longitudinalrecesses 860 are dimensioned to accept two or more bosses 880 located atcorresponding locations on the needle guard 540. Because of these twofeatures, clockwise rotation of the safety cap 800 causes correspondingrotation of the needle guard 540 and the needle holder 260. Thus, theuser may turn the safety cap 800 clockwise one quarter turn, prior toremoving it from the device, to create the drug path and prepare thedevice for injection.

The device of the preferred embodiment is operated by first turning thesafety cap 800 clockwise one quarter of a turn, to create the drug pathby inserting the proximal end of injecting needle 480 into the ampule320. Rotating the safety cap 800 also aligns the cutaways 645 in thesafety cap 560 with the bosses 625 on the inner housing 25, allowing theneedle guard 540 to be depressed. Next the safety cap 800 andconsequently the needle cap 820 are removed from the device. As thedistal end of the device is pressed against the injection site, theneedle guard 540 moves longitudinally toward the proximal end of thedevice and the injecting needle 480 enters the skin to a depth ofbetween 1 and 5 mm. The movement of the needle guard 540 causes the ram125 to fire and consequently between 0.02 and 2.0 ml of medicament 400is forced out of the ampule 320 and through the drug path in under about2.75 seconds. Once the device is removed from the injection site, theneedle guard 540 returns to its original position under the force ofreturn spring 660, concealing the injecting needle 480. The locking ring700 locks the needle guard 540 in place to prevent re-exposure of theinjecting needle 480. Alternatively, a push button could be located atthe proximal end of the device and be locked in an idle position. Themovement of the needle guard 540 could unlock the push button and allowthe user to depress it and consequently fire the device.

FIG. 20 b shows another embodiment of the cartridge assembly 302 of thepreferred embodiment. The cartridge assembly 302 comprises a glassampule 322 and a needle assembly 462 sealed on its distal end. Apierceable seal 422 is located in proximity to the proximal end of theinjecting needle 482 and creates a barrier between the medicament 402and the injecting needle 482. A rubber stopper 382 is slideable withinthe glass ampule 322 and seals an opening 342 in its proximal end so themedicament 402 stays inside the glass ampule 322. Upon firing of theinjector, the ram 125 urges the rubber stopper 382 toward the distal endof the injector. Since the medicament 402 is an incompressible fluid,the pierceable seal 422 is forced onto the distal end of the injectingneedle 482, thereby breaking the barrier and creating the drug path.With this cartridge assembly 302, no turning of the device is requiredto create the drug path, and the threads on the inner housing 25 and onthe needle holder 260 can be replaced by known permanent fixingtechniques, such as gluing or welding.

A significant advantage of the needle assisted jet injector according tothe present invention is that it allows for a lower pressure to deliverthe medicament at the desired rate. In this regard, administering aninjection using either a fixed or retractable needle requires lessenergy and force than conventional jet injector devices. FIG. 27 shows apressure-time curve for a jet injector. The peak pressure at point c isthe pressure needed to penetrate the skin and point d and beyond is thepressure at which a jet stream of medicament is delivered. As shown inthe chart below, needle assisted jet injectors do not need to achieve ashigh as peak pressure as conventional jet injectors because the outerlayer of skin is penetrated by the needle. Pressure and Time (sec.) toInject 1 cc Pressure 26 Gauge needle 27 Gauge needle 150 psi 2.1 4.2 200psi 1.9 3.9 240 psi 1.7 3.3 375 psi 1.4 3.1

A lower peak pressure can be used to deliver the medicament to thedesired region and still achieve a short injection time. It is alsopossible that a lower steady state pressure can be used to deliver thejet stream after the needle and the jet injection have reached thedesired region.

Reduced operating pressure decreases the chances of glass ampulebreakage. The chart below shows the statistical predictions of breakagefor glass cartridges at different pressures, based on the Gausiandistribution of actual breakage rates at various pressures. BreakageRates for Glass Cartridges Pressure (psi) Breakage Rate 310 1.5 × 10⁻¹¹412 1.0 × 10⁻⁹ 

It can be seen that a relatively small increase in pressure (□ 100p.s.i. (689 kPa)) increases the breakage rate by two orders ofmagnitude. Thus, the reduced operating pressure of the needle assistedinjection device of the present invention greatly reduces the risk ofampule breakage.

Experimentation has confirmed that the needle assisted injectoraccording to the present invention can be operated using a lowergenerating energy source and still maintain the quality of theinjection. Specifically, experimentation has shown that a higherpercentage of successful injections can be achieved with a needleassisted jet injector having a needle that penetrates the skin to adepth of 1 mm and 20 lb. (89 N) force generating means as with aconventional needleless jet injectors having 55 lb. (2445 N) forcegenerating means. Similar results have been achieved with needles thatpenetrate 1-3 mm and force generating sources providing 20 lbs. and 40lbs. (89 to 178 N) of force.

Another advantage of the needle assisted jet injector according to thepresent invention, shown in the chart below, is the decreased injectiontime compared to syringes or auto-injectors. Comparison of OperatingProperties for Injection Devices Dia. Of Spring Fluid Avg. Volume ofForce Chamber Pressure Injection Injection (Lbf.) (inches) (psi) (ml)Time (sec) Jet Injector 110 0.233 2111 0.5 0.165 1^(st) Needle 30 0.352227 0.5 <1 Assisted Injector 2^(nd) Needle 15 0.231 233 0.5 <1 AssistedInjector Conventional N/A 0.351 5 0.5 3-5 Syringe

As previously discussed, auto-injectors and syringes have injectiontimes of several seconds or more. During this injection time, thequality of the injection can be compromised due to any number offactors. For example, the patient could move the syringe orauto-injector prior to completion of the injection. Such movement couldoccur either accidentally or intentionally because of injection-relatedpain. In contrast, the needle assisted jet injector, like other jetinjectors, can have an injection time of less than 1 second. The shortinjection time minimizes the possibility of compromising the quality ofthe injection.

While it is apparent that the illustrative embodiments of the inventionherein disclosed fulfill the objectives stated above, it will beappreciated that numerous modifications and other embodiments may bedevised by those skilled in the art. Therefore, it will be understoodthat the appended claims are intended to cover all such modificationsand embodiments which come within the spirit and scope of the presentinvention.

1. A jet injection device, comprising: a housing member having distaland proximal ends; a fluid chamber within the housing member for holdingabout between 0.02 ml and 3 ml of a medicament; an injection-assistingneedle disposed at the distal end of the housing member, having aninjecting end, and having an association with the fluid chamber toprovide a fluid pathway from the fluid chamber through the needle; aplunger movable within the fluid chamber; and a force generating sourcecapable of providing sufficient force on the plunger to eject an amountof the medicament from the fluid chamber through the needle; wherein theinjecting end of the needle has a position extending from the housingmember by a length selected for inserting into a patient to a needleinsertion point at a depth of up to about 5 mm; and wherein the forcegenerating source is configured such that activation of the forcegenerating source moves the plunger to apply a pressure to themedicament in the fluid chamber reaching about between 100 and 1000p.s.i. to expel medicament from the fluid chamber and eject the amountof the medicament through the injecting end.
 2. The jet injection deviceof claim 1, wherein the injection site is subcutaneous.
 3. The jetinjection device of claim 1, wherein the needle insertion point is at adepth of between about 1 mm and 5 mm.
 4. The jet injection device ofclaim 1, wherein the needle insertion point is at a depth of up to about3 mm.
 5. The jet injection device of claim 1, wherein the forcegenerating source and needle are configured such that the medicament isinjected at a rate of at least 0.40 ml/sec upon activation of the forcegenerating source.
 6. The jet injection device of claim 1, wherein theforce generating source and needle are configured to inject themedicament is injected to the injection site in less than about 2.75seconds.
 7. The jet injection device of claim 1, wherein the forcegenerating source and needle are configured to inject the medicament isinjected at a rate so that about 1 ml of the medicament is ejected inabout 2 seconds.
 8. The jet injection device of claim 1, wherein theforce generating source and needle are configured to apply to themedicament a pressure that reaches up to about 500 p.s.i.
 9. The jetinjection device of claim 8, wherein the force generating source andneedle are configured to apply to the medicament a pressure that reachesbetween about 150 and 375 p.s.i.
 10. The jet injection device of claim1, wherein the needle injecting end has a discharge orifice throughwhich the medicament is ejected, the orifice having a diameter of aboutbetween 0.004 to 0.012 inches and the needle has a length of betweenabout 1 mm and 5 mm.
 11. The jet injection device of claim 1, whereinthe needle has a gauge of 26 or
 27. 12. The jet injection device ofclaim 1, wherein the needle comprises: a injecting end portion that isinsertable into the patient to the needle insertion point; and aproximal portion that has common axial cross-sectional dimensions as theinjecting end portion and extends proximally into an injection devicehousing member in which the fluid chamber is disposed during theejection of the medicament, the proximal portion being longer than theinjecting end portion.
 13. The jet injection device of claim 12, whereinthe proximal and injecting end portions have substantially common andcontinuous inner and outer diameters.
 14. The jet injection device ofclaim 1, wherein the fluid chamber is made of glass.
 15. The jetinjection device of claim 1, wherein the housing member has a concealingassociation with the needle, wherein the device is configured such thatthe needle injecting end is extendable from the housing member to allowthe insertion to the needle insertion point.
 16. The jet injectiondevice of claim 15, wherein the housing member comprises a needle shieldlocated at the distal end of the housing member for concealing theneedle, the needle shield being moveable between: a protecting position,in which the needle is disposed within the guard prior to activation,and an injecting position, in which the tip of the needle is exposed forinsertion to the insertion point.
 17. The jet injection device of claim16, further comprising an activation element operatively associated withthe shield such that the activation element activates the forcegenerating source upon retraction of the shield from the protectingposition to the injection position.
 18. The jet injection device ofclaim 1, further comprising a retraction element configured forretracting the needle into the housing member after the medicament isejected.
 19. The jet injection device of claim 1, wherein the housingmember and needle are cooperatively associated to allow the insertion ofthe needle to the insertion point.
 20. The jet injection device of claim1, wherein the force generating source and needle are configured toexpel medicament from the fluid chamber and eject the amount of themedicament through the injecting end and past the insertion point to aninjection site that is deeper than the needle insertion point.
 21. A jetinjection device, comprising: a housing member having distal andproximal ends; a fluid chamber within the housing member for holding atleast about 0.02 ml to 3 ml of a medicament; an injection-assistingneedle disposed at the distal end of the housing member, having aninjecting end, and having an association with the fluid chamber toprovide a fluid pathway from the fluid chamber through the needle; aplunger movable within the fluid chamber; and a force generating sourcecapable of providing sufficient force on the plunger to eject an amountof the medicament from the fluid chamber through the needle; wherein theinjecting end of the needle has a position extending from the housingmember by a length selected for inserting into a patient to a needleinsertion point at a depth of up to about 5 mm; and wherein the forcegenerating source is configured such that activation of the forcegenerating source moves the plunger to apply a pressure to themedicament in the fluid chamber to expel medicament from the fluidchamber and eject the amount of the medicament by a through theinjecting end and past the insertion point to an injection site thepressure being about between 100 and 1000 p.s.i. while the medicament isbeing ejected.